Purpose To update the recommendations for the use of tumor marker tests in the prevention,
screening, treatment, and surveillance of gastrointestinal cancers. Methods For the 2006 …

OBJECTIVE: To update the 1997 clinical practice guidelines for the use of tumor marker
tests in the prevention, screening, treatment, and surveillance of breast and colorectal …

In recent years, numerous serum and cell/tissue-based markers have been described for
colorectal cancer (CRC). The aim of this article was to provide guidelines for the routine …

INTRODUCTION: The aim of the study was to evaluate the diagnostic precision of serum
carcinoembryonic antigen (CEA) in the detection of local or distant recurrence following …

Carcinoembryonic antigen (CEA) monitoring in patients with stage I-IV colorectal cancer has
been, and remains, a controversial issue in oncology practice. Recommendations vary from …

Objectives Carcinoembryonic antigen (CEA) is a reliable tumor marker for the management
and surveillance of colon cancer. However, limitations in previous studies have made it …

Background: Carcinoembryonic antigen (CEA) is one of the most widely used tumor markers
worldwide. Its main application is mostly in gastrointestinal cancers, especially in colorectal …

Abstract Introduction Carcinoembryonic Antigen (CEA) has been used as a tumor marker in
the follow-up of colorectal cancer for more than 40 years. Controversy exists regarding its …

Carcinoembryonic antigen (CEA) is not normally produced in significant quantities after birth
but is elevated in colorectal cancer. The aim of this review was to define the current role of …

The appropriate use of plasma carcinoembryonic antigen (CEA) levels in the management
of patients with colorectal cancer has been debated over the last 30 years. It is clear from the …